Eli Lilly has released a completely new application that enables self-pay back people to purchase the weight-loss drug Zepbound for as little as $399 a month—less than 50 % the record price of other incretin medicines employed for sufferers with obesity.It’s even more effective than its rival, semaglutide, promoted as copyright for type 2 diabe… Read More